Advanced Search

Publications > Journals > Journal of Exploratory Research in Pharmacology > Special Issue

Natural active ingredient–based nanodrug delivery system for cancer treatment

Submit your manuscript

  • Special Issue Information
  • Articles
Topic Editors

Natural products (NPs) have present abundant scaffold diversity and structural complexity, and have contributed greatly in drug discovery efforts especially for anticancer drugs. As an example, Professor Youyou Tu was awarded the 2015 Nobel Prize for discovering artemisinin from Artemisia annua. While natural active ingredients are important sources of novel anticancer drugs, NPs often exhibit unfavorable physicochemical and pharmacokinetics properties, such as low solubility, poor bioavailability, and systemic toxicity, which limit their potential for clinical application. Thus, nanodrug delivery systems, such as liposomes, polymer colloids, carbon nanomaterials, metal-organic framework, and magnetic nanocarriers, have been developed to overcome the unsuitable properties of NPs and improve their therapeutic efficacy for cancer.

For this special issue, we invite front-line researchers and scientists to submit high-quality scientific manuscripts related to the development of nanodrug delivery systems for cancer treatment. Potential topics include, but are not limited to:

  • New nanomaterials and nanotechnologies used in nanoparticles for NP delivery 
  • NP nanodelivery systems with systemic antitumor properties 
  • Targeted delivery and controlled release of NP-based nanomedicine 
  • Intelligent theranostic NP-based nanomedicine 
  • Carrier-free NP nanoplatforms 
  • Antitumor mechanism of nanoparticles for NP delivery 
  • Clinical studies of nanoparticles for NP delivery 

Priority will be given with the same high standards of peer review and publication process for these articles. All publications will open free access to all readers. We guarantee that all accepted papers related to AI in Liver Disease will be highlighted in a special section on our website.

Publication date: An article will be published online as soon as it is accepted.

Guest Editor

Han Chao

Read More

Chao Han received his PhD in Medicinal Chemistry in 2016 from China Pharmaceutical University, where he has been working ever since.

Guest Editor

Zhongrui Li

Read More

Zhongrui Li received her PhD in Medicinal Chemistry in 2019 from Zhengzhou University and continued her 2-year postdoctoral research at Nanjing Medical University.

Important Dates

Submission open date: April 11, 2022

Submission deadline: October 31, 2022